| Encapsulation of temozolomide in a calixarene nanocapsule improves its stability and enhances its therapeutic efficacy against glioblastoma A Renziehausen, AD Tsiailanis, R Perryman, EK Stylos, C Chatzigiannis, ... Molecular cancer therapeutics 18 (9), 1497-1505, 2019 | 34 | 2019 |
| Exploring the oxidation and iron binding profile of a cyclodextrin encapsulated quercetin complex unveiled a controlled complex dissociation through a chemical stimulus DA Diamantis, S Ramesova, CM Chatzigiannis, I Degano, PS Gerogianni, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1862 (9), 1913-1924, 2018 | 29 | 2018 |
| Host–Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II … D Ntountaniotis, I Andreadelis, TF Kellici, V Karageorgos, G Leonis, ... Molecular Pharmaceutics 16 (3), 1255-1271, 2019 | 22 | 2019 |
| Development of bioactive gemcitabine-D-Lys6-GnRH prodrugs with linker-controllable drug release rate and enhanced biopharmaceutical profile N Sayyad, EI Vrettos, T Karampelas, CM Chatzigiannis, K Spyridaki, ... European journal of medicinal chemistry 166, 256-266, 2019 | 21 | 2019 |
| Exploring the role of the membrane bilayer in the recognition of candesartan by its GPCR AT1 receptor S Kiriakidi, C Chatzigiannis, C Papaemmanouil, AG Tzakos, ... Biochimica et Biophysica Acta (BBA)-Biomembranes 1862 (3), 183142, 2020 | 17 | 2020 |
| Unveiling the interaction profile of rosmarinic acid and its bioactive substructures with serum albumin C Papaemmanouil, MV Chatziathanasiadou, C Chatzigiannis, ... Journal of Enzyme Inhibition and Medicinal Chemistry 35 (1), 786-804, 2020 | 16 | 2020 |
| Interplay of cholesterol, membrane bilayers and the AT1R: A cholesterol consensus motif on AT1R is revealed S Kiriakidi, C Chatzigiannis, C Papaemmanouil, AG Tzakos, Z Cournia, ... Computational and Structural Biotechnology Journal 19, 110-120, 2021 | 7 | 2021 |
| Chemical Profiling, Bioactivity Evaluation and the Discovery of a Novel Biopigment Produced by Penicillium purpurogenum CBS 113139 AD Tsiailanis, C Pateraki, M Kyriazou, CM Chatzigiannis, ... Molecules 27 (1), 69, 2021 | 5 | 2021 |
| Exploration of Betalains and Determination of the Antioxidant and Cytotoxicity Profile of Orange and Purple Opuntia spp. Cultivars in Greece AD Tsiailanis, CM Chatzigiannis, CD Papaemmanouil, ... Plant Foods for Human Nutrition 77 (2), 198-205, 2022 | 3 | 2022 |
| 2D DOSY NMR: a valuable tool to confirm the complexation in drug delivery systems CM Chatzigiannis, S Kiriakidi, AG Tzakos, T Mavromoustakos Supramolecules in Drug Discovery and Drug Delivery: Methods and Protocols …, 2021 | 3 | 2021 |
| Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen AD Tsiailanis, CC Tellis, P Papakyriakopoulou, AD Kostagianni, ... Molecules 28 (5), 2311, 2023 | 1 | 2023 |
| Immunomodulatory properties of HYCOs, NRF2 activators that simultaneously release carbon monoxide (CO) to cells and tissues G Stegnjaić, D Mićanović, N Nikolovski, M Momčilović, T Saksida, ... 5th Scientific Meeting of the COST Action CA20121: Bench to Bedside …, 2023 | | 2023 |
| Nrf2 down-regulation mediates pro-inflammatory effects of novel synthetic AhR ligands I Koprivica, N Jonić, C Chatzigiannis, A Tsiailanis, AG Tzakos, ... 5th Scientific Meeting of the COST Action CA20121: Bench to Bedside …, 2023 | | 2023 |
| Development of a novel compound that upregulates Treg in the gut by modulating aryl hydrocarbon receptor's activity N Jonić, CM Chatzigiannis, I Koprivica, S Marinho, P Moura-Alves, ... Program and Abstracts: 12th EFIS-EJI South Eastern European Immunology …, 2023 | | 2023 |
| Novel aryl hydrocarbon receptor modulator promotes immunosupressive immune response by stimulating T regulatory cells in the gut N Jonić, CM Chatzigiannis, I Koprivica, S Marinho, P Moura-Alves, ... CoMBoS2–the Second Congress of Molecular Biologists of Serbia, Abstract Book …, 2023 | | 2023 |
| Novosintetisani fluorescentni AhR ligand podstiče povećanje udela T regulatornih ćelija i ublažava kliničku sliku dijabetesa tipa 1 kod C57BL/6 miševa N Jonić, CM Chatzigiannis, I Koprivica, S Marinho, P Moura-Alves, ... Naučni skup Svetski dan imunologije 2023; 2023 Apr 27; Belgrade, Serbia, 2023 | | 2023 |
| Cytidine Derivatives and Methods of Forming Cytidine Derivatives A Tzakos, G Sivolapenko, C Chatzigiannis US Patent App. 17/605,794, 2022 | | 2022 |
| Novel BCL2 inhibitors with anti-lymphoma activity AA Mensah, CM Chatzigiannis, DA Diamantis, VK Gkalpinos, A Arribas, ... Cancer Research 82 (12_Supplement), 3942-3942, 2022 | | 2022 |
| Promoting the pro-inflammatory phenotype in macrophages by blocking the aryl hydrocarbon receptor N Jonić, CM Chatzigiannis, I Koprivica, A Savić, D Mićanović, T Saksida, ... Serbian Biochemical Society Tenth Conference: with international …, 2021 | | 2021 |
| Novel aryl hydrocarbon receptor antagonist promotes macrophage pro-inflammatory phenotype N Jonić, CM Chatzigiannis, I Koprivica, A Savic, D Gajić, T Saksida, ... 6th European Congress of Immunology; 2021 Sep 1-4; Virtual Meeting, 207, 2021 | | 2021 |
Andreas TzakosAssociate ProfessorVerified email at cc.uoi.gr
